IIM
PYXS icon

INTECH Investment Management’s Pyxis Oncology PYXS Stock Holding History

INTECH Investment Management’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-32,173
Closed -$31.5K – 2625
2025
Q1 		$31.5K Buy
32,173
+9,682
+43% +$12.9K ﹤0.01% 2477
2024
Q4 		$35.1K Buy
22,491
+7,594
+51% +$21.9K ﹤0.01% 2357
2024
Q3 		$54.7K Buy
+14,897
New +$52.1K ﹤0.01% 1974

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

INTECH Investment Management's PYXS Position: Q2 2025 in Review

INTECH Investment Management sold out of Pyxis Oncology (PYXS) in Q2 2025, closing a stake of 32,173 shares — an estimated $31.5K sold.

INTECH Investment Management first reported a position in PYXS in Q3 2024 and held it in 3 quarters. The position peaked at $54.7K in Q3 2024. 74 funds tracked by Wall St. Rank hold PYXS as of Q2 2025.

  • INTECH Investment Management reported no remaining Pyxis Oncology position as of Q2 2025 after selling out during the quarter.
  • INTECH Investment Management sold 32,173 Pyxis Oncology shares in Q2 2025, an estimated $31.5K.
  • INTECH Investment Management first reported a position in Pyxis Oncology in Q3 2024 and held it in 3 quarters.
  • INTECH Investment Management's Pyxis Oncology position peaked at $54.7K in Q3 2024.
  • 74 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2025.

Based on INTECH Investment Management's 13F filing for Q2 2025, filed 8 Aug 2025.